AHR and breast carcinoma: There is extensive support from cell culture and in vivo studies indicating that the AhR is a target for breast cancer therapy [23] and human clinical trials using the AhR ligand “aminoflavone” have been carried out for treating breast and other cancers [24,25,26,27].